CMV remains an area of huge unmet medical need. Despite decades of research, no CMV vaccine has been approved to date, underscoring the importance of these new discoveries COPENHAGEN, Denmark, ...

Evaxion's AI-ImmunologyTM platform has discovered novel CMV antigens that significantly reduce viral infection in preclinical models EVX-V1 is a next-generation, multi-component vaccine program ...

Evaxion’s AI-Immunology™ platform has discovered novel CMV antigens that significantly reduce viral infection in preclinical models EVX-V1 is a next-generation, multi-component vaccine program ...

Investing.com -- Evaxion Biotech AS (NASDAQ:EVAX) stock surged 10.6% on Thursday after the clinical-stage TechBio company announced significant progress in its cytomegalovirus (CMV) vaccine program, ...

DUBAI, United Arab Emirates, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM) is entering its most important stage yet. The team has confirmed that the first public version of its lending ...

TIOBE Index for December 2025: Top 10 Most Popular Programming Languages Your email has been sent December’s TIOBE Index lands with a quieter top tier but a livelier shuffle just beneath it. The main ...